The Effect of Atorvastatin on Cardiometabolic Risk Factors in Bromocriptine-Treated Premenopausal Women With Isolated Hypercholesterolemia

Cardiovascular Therapeutics - United Kingdom
doi 10.1111/1755-5922.12143

Related search